Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
June-2020 Volume 19 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2020 Volume 19 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Improved telangiectasia and reduced recurrence rate of rosacea after treatment with 540 nm‑wavelength intense pulsed light: A prospective randomized controlled trial with a 2‑year follow‑up

  • Authors:
    • Yang Luo
    • Xiu‑Li Luan
    • Jian‑Hong Zhang
    • Lan‑Xi Wu
    • Nan Zhou
  • View Affiliations / Copyright

    Affiliations: Department of Dermatology, The 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Lanzhou, Gansu 730050, P.R. China
    Copyright: © Luo et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 3543-3550
    |
    Published online on: March 20, 2020
       https://doi.org/10.3892/etm.2020.8617
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to evaluate the clinical efficacy and safety of 540 nm-wavelength intense pulsed light (IPL) for the treatment of telangiectasia in late‑stage rosacea. Between July 2013 and January 2016, patients with rosacea who tested positive for Demodex folliculorum were recruited. Patients received anti‑mite therapy and were then randomly apportioned to receive either three 540 nm‑IPL treatments at 4‑week intervals (IPL group), or no treatment (control group). Telangiectasia was assessed by the same clinician at baseline and at follow‑up intervals over 2 years, where ≥90% clearance of telangiectasia was considered to indicate effective treatment. The rates of effective treatment, improvement (≥30% clearance) and recurrence (original or neo‑location) were compared in both groups. After 33 patients were lost during follow‑up, the IPL and control groups were comprised of 107 and 120 patients for the final analysis, respectively. The rates of effective treatment and total efficacy in the IPL group (66.36 and 95.33%, respectively) were found to be significantly higher compared with those of the control group (0 and 30.83%, respectively). By contrast, the rates of recurrence were found to be lower in the IPL group (8.41%) compared with the control group (48.33%). Redness‑to‑blisters associated with IPL treatment (9.7% of analyzed patients) subsided within one week and hyperpigmentation (1.9%) within 3 months. To conclude, treatment with 540 nm‑IPL improved facial telangiectasia in late‑stage rosacea that remained after sequential anti‑mite therapy and effectively reduced the recurrence of rosacea. The present study was registered into the Chinese Clinical Trial Registry under the title ‘Sequential therapy for mites folliculitis’ (Trial registration number: ChiCTR‑IPR‑15006451; approved May 27, 2015).
View Figures

Figure 1

Figure 2

Figure 3

View References

1 

Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R and Powell F: National Rosacea Society Expert C. Standard grading system for rosacea: Report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 50:907–912. 2004.PubMed/NCBI View Article : Google Scholar

2 

Crawford GH, Pelle MT and James WD: Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 51:327–341; quiz 342-324. 2004.PubMed/NCBI View Article : Google Scholar

3 

Wacker T and Lang GK: Demodex folliculorum: Diagnosis and therapy today. Klin Monbl Augenheilkd (German). 231:241–245. 2014.PubMed/NCBI View Article : Google Scholar

4 

Alinia H, Tuchayi SM, James SM, Cardwell LA, Nanda S, Bahrami N, Awosika O, Richardson I, Huang KE and Feldman SR: Measurement of disease severity in a population of rosacea patients. Dermatol Clin. 36:97–102. 2018.PubMed/NCBI View Article : Google Scholar

5 

Oussedik E, Bourcier M and Tan J: Psychosocial burden and other impacts of rosacea on patients' quality of life. Dermatol Clin. 36:103–113. 2018.PubMed/NCBI View Article : Google Scholar

6 

Egeberg A, Hansen PR, Gislason GH and Thyssen JP: Patients with rosacea have increased risk of dementia. Ann Neurol. 79:921–928. 2016.PubMed/NCBI View Article : Google Scholar

7 

Faris C, Manjaly JG, Ismail-Koch H and Caldera S: Rapid treatment of rhinophyma with powered microdebrider. Case Rep Otolaryngol. 2013(621639)2013.PubMed/NCBI View Article : Google Scholar

8 

Egeberg A, Hansen PR, Gislason GH and Thyssen JP: Patients with rosacea have increased risk of depression and anxiety disorders: A danish nationwide cohort study. Dermatology. 232:208–213. 2016.PubMed/NCBI View Article : Google Scholar

9 

Gallo RL, Granstein RD, Kang S, Mannis M, Steinhoff M, Tan J and Thiboutot D: Standard classification and pathophysiology of rosacea: The 2017 update by the National Rosacea Society Expert Committee. J Am Acad Dermatol. 78:148–155. 2018.PubMed/NCBI View Article : Google Scholar

10 

Micali G, Dall'Oglio F, Verzi AE, Luppino I, Bhatt K and Lacarrubba F: Treatment of erythemato-telangiectatic rosacea with brimonidine alone or combined with vascular laser based on preliminary instrumental evaluation of the vascular component. Lasers Med Sci. 33:1397–1400. 2018.PubMed/NCBI View Article : Google Scholar

11 

Kennedy Carney C, Cantrell W and Elewski BE: Rosacea: A review of current topical, systemic and light-based therapies. G Ital Dermatol Venereol. 144:673–688. 2009.PubMed/NCBI

12 

Del Rosso JQ, Tanghetti EA, Baldwin HE, Rodriguez DA and Ferrusi IL: The burden of illness of erythematotelangiectatic rosacea and papulopustular rosacea: Findings from a web-based survey. J Clin Aesthet Dermatol. 10:17–31. 2017.PubMed/NCBI

13 

Luo Y, Sun YJ, Zhang L and Luan XL: Treatment of mites folliculitis with an ornidazole-based sequential therapy: A randomized trial. Medicine (Baltimore). 95(e4173)2016.PubMed/NCBI View Article : Google Scholar

14 

Luo Y, Luan XL, Sun YJ, Zhang L and Zhang JH: Effect of recombinant bovine basic fibroblast growth factor gel on repair of rosacea skin lesions: A randomized, single-blind and vehicle-controlled study. Exp Ther Med. 17:2725–2733. 2019.PubMed/NCBI View Article : Google Scholar

15 

Anzengruber F, Czernielewski J, Conrad C, Feldmeyer L, Yawalkar N, Hausermann P, Cozzio A, Mainetti C, Goldblum D, Goldblum D, et al: Swiss S1 guideline for the treatment of rosacea. J Eur Acad Dermatol Venereol. 31:1775–1791. 2017.PubMed/NCBI View Article : Google Scholar

16 

Lowe E and Lim S: Paradoxical erythema reaction of long-term topical brimonidine gel for the treatment of facial erythema of rosacea. J Drugs Dermatol. 15:763–765. 2016.PubMed/NCBI

17 

Husain Z and Alster TS: The role of lasers and intense pulsed light technology in dermatology. Clin Cosmetic and Invest Dermatol. 9:29–40. 2016.PubMed/NCBI View Article : Google Scholar

18 

Tanghetti EA, Jackson JM, Belasco KT, Friedrichs A, Hougier F, Johnson SM, Kerdel FA, Palceski D, Hong HC, Hinek A and Cadena MJ: Optimizing the use of topical brimonidine in rosacea management: Panel recommendations. J Drugs Dermatol. 14:33–40. 2015.PubMed/NCBI

19 

Gao L, Gao N, Song W, Dang E, Yin R, Wang L and Wang G: A retrospective study on efficacy of pulsed dye laser and intense pulsed light for the treatment of facial telangiectasia. J Drugs Dermatol. 16:1112–1116. 2017.PubMed/NCBI

20 

Jansen T: Clinical presentations and classification of rosacea. Ann Dermatol Venereol. 138:S192–S200. 2011.PubMed/NCBI View Article : Google Scholar

21 

Jansen T: Clinical presentations and classification of rosacea. Ann Dermatol Venereol. 138 (Suppl):S138–S147. 2011.PubMed/NCBI View Article : Google Scholar

22 

Fitzpatrick TB: The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 124:869–871. 1988.PubMed/NCBI View Article : Google Scholar

23 

Goldberg DJ: Current trends in intense pulsed light. J Clin Aesthet Dermatol. 5:45–53. 2012.PubMed/NCBI

24 

Dummer R, Graf P, Greif C and Burg G: Treatment of vascular lesions using the VersaPulse variable pulse width frequency doubled neodymium: YAG laser. Dermatology. 197:158–161. 1998.PubMed/NCBI View Article : Google Scholar

25 

Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R and Powell F: Standard classification of rosacea. National Rosacea Society Expert Committee: Report of the National Rosacea Society Expert Committee on the classification and staging of Rosacea. J Am Acad Dermatol. 46:584–587. 2002.PubMed/NCBI View Article : Google Scholar

26 

Xu Z, Tan X, Ye J, Zhang C, Zhao M and Zhan F: Evaluation of measles catch-up immunization campaign in Hubei, 2010. Chin J Viral Dis. 1:208–211. 2011.

27 

Cribier B: Pathophysiology of rosacea: Redness, telangiectasia, and rosacea. Ann Dermatol Venereol. 138 (Suppl):S184–S191. 2011.PubMed/NCBI View Article : Google Scholar

28 

Agnoletti AF, DEC E, Parodi A, Schiavetti I, Savarino V, Rebora A, Paolino S, Cozzani E and Drago F: Etiopathogenesis of rosacea: A prospective study with a three-year follow-up. G Ital Dermatol Venereol. 152:418–423. 2017.PubMed/NCBI View Article : Google Scholar

29 

Forton FM: Papulopustular rosacea, skin immunity and Demodex: Pityriasis folliculorum as a missing link. J Eur Acad Dermatol Venereol. 26:19–28. 2012.PubMed/NCBI View Article : Google Scholar

30 

Turgut Erdemir A, Gurel MS, Koku Aksu AE, Falay T, Inan Yuksel E and Sarikaya E: Demodex mites in acne rosacea: Reflectance confocal microscopic study. Australas J Dermatol. 58:e26–e30. 2017.PubMed/NCBI View Article : Google Scholar

31 

Abokwidir M and Feldman SR: Rosacea management. Skin Appendage Disord. 2:26–34. 2016.PubMed/NCBI View Article : Google Scholar

32 

Campolmi P, Bonan P, Cannarozzo G, Bruscino N, Troiano M, Prignano F and Lotti T: Intense pulsed light in the treatment of non-aesthetic facial and neck vascular lesions: Report of 85 cases. J Eur Acad Dermatol Venereol. 25:68–73. 2011.PubMed/NCBI View Article : Google Scholar

33 

Liu J, Liu J, Ren Y, Li B and Lu S: Comparative efficacy of intense pulsed light for different erythema associated with rosacea. J Cosmet Laser Ther. 16:324–327. 2014.PubMed/NCBI View Article : Google Scholar

34 

Wong WR, Shyu WL, Tsai JW, Hsu KH, Lee HY and Pang JHS: Intense pulsed light modulates the expressions of MMP-2, MMP-14 and TIMP-2 in skin dermal fibroblasts cultured within contracted collagen lattices. J Dermatol Sci. 51:70–73. 2008.PubMed/NCBI View Article : Google Scholar

35 

Vigo L, Giannaccare G, Sebastiani S, Pellegrini M and Carones F: Intense pulsed light for the treatment of dry eye owing to meibomian gland dysfunction. J Vis Exp. 146:2019.PubMed/NCBI View Article : Google Scholar

36 

Rainer BM, Kang S and Chien AL: Rosacea: Epidemiology, pathogenesis, and treatment. Dermatoendocrinol. 9(e1361574)2017.PubMed/NCBI View Article : Google Scholar

37 

Lim HS, Lee SC, Won YH and Lee JB: The efficacy of intense pulsed light for treating erythematotelangiectatic rosacea is related to severity and age. Ann Dermatol. 26:491–495. 2014.PubMed/NCBI View Article : Google Scholar

38 

Babilas P, Schreml S, Szeimies RM and Landthaler M: Intense pulsed light (IPL): A review. Lasers Surg Med. 42:93–104. 2010.PubMed/NCBI View Article : Google Scholar

39 

Kawana S, Ochiai H and Tachihara R: Objective evaluation of the effect of intense pulsed light on rosacea and solar lentigines by spectrophotometric analysis of skin color. Dermatol Surg. 33:449–454. 2007.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Luo Y, Luan XL, Zhang JH, Wu LX and Zhou N: Improved telangiectasia and reduced recurrence rate of rosacea after treatment with 540 nm‑wavelength intense pulsed light: A prospective randomized controlled trial with a 2‑year follow‑up. Exp Ther Med 19: 3543-3550, 2020.
APA
Luo, Y., Luan, X., Zhang, J., Wu, L., & Zhou, N. (2020). Improved telangiectasia and reduced recurrence rate of rosacea after treatment with 540 nm‑wavelength intense pulsed light: A prospective randomized controlled trial with a 2‑year follow‑up. Experimental and Therapeutic Medicine, 19, 3543-3550. https://doi.org/10.3892/etm.2020.8617
MLA
Luo, Y., Luan, X., Zhang, J., Wu, L., Zhou, N."Improved telangiectasia and reduced recurrence rate of rosacea after treatment with 540 nm‑wavelength intense pulsed light: A prospective randomized controlled trial with a 2‑year follow‑up". Experimental and Therapeutic Medicine 19.6 (2020): 3543-3550.
Chicago
Luo, Y., Luan, X., Zhang, J., Wu, L., Zhou, N."Improved telangiectasia and reduced recurrence rate of rosacea after treatment with 540 nm‑wavelength intense pulsed light: A prospective randomized controlled trial with a 2‑year follow‑up". Experimental and Therapeutic Medicine 19, no. 6 (2020): 3543-3550. https://doi.org/10.3892/etm.2020.8617
Copy and paste a formatted citation
x
Spandidos Publications style
Luo Y, Luan XL, Zhang JH, Wu LX and Zhou N: Improved telangiectasia and reduced recurrence rate of rosacea after treatment with 540 nm‑wavelength intense pulsed light: A prospective randomized controlled trial with a 2‑year follow‑up. Exp Ther Med 19: 3543-3550, 2020.
APA
Luo, Y., Luan, X., Zhang, J., Wu, L., & Zhou, N. (2020). Improved telangiectasia and reduced recurrence rate of rosacea after treatment with 540 nm‑wavelength intense pulsed light: A prospective randomized controlled trial with a 2‑year follow‑up. Experimental and Therapeutic Medicine, 19, 3543-3550. https://doi.org/10.3892/etm.2020.8617
MLA
Luo, Y., Luan, X., Zhang, J., Wu, L., Zhou, N."Improved telangiectasia and reduced recurrence rate of rosacea after treatment with 540 nm‑wavelength intense pulsed light: A prospective randomized controlled trial with a 2‑year follow‑up". Experimental and Therapeutic Medicine 19.6 (2020): 3543-3550.
Chicago
Luo, Y., Luan, X., Zhang, J., Wu, L., Zhou, N."Improved telangiectasia and reduced recurrence rate of rosacea after treatment with 540 nm‑wavelength intense pulsed light: A prospective randomized controlled trial with a 2‑year follow‑up". Experimental and Therapeutic Medicine 19, no. 6 (2020): 3543-3550. https://doi.org/10.3892/etm.2020.8617
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team